Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXtract Regulatory News (XTR)

Share Price Information for Xtract (XTR)

Share Price is delayed by 15 minutes
Get Live Data
1.25    0.15 (13.64%)
Bid:
1.20
Ask:
1.30
Spread: 0.10 (8.333%)
Market Cap: £10.70m
XTR Live PriceLast checked at - London Stock Exchange

Intraday Xtract Share Chart

Auroch Loan Note Conversion

28 Mar 2017 15:19

RNS Number : 7922A
Xtract Resources plc
28 March 2017
Β 

Β 

For immediate release

Β 28 March 2017

Β 

Xtract Resources Plc

("Xtract" or the "Company")

Β Auroch loan note conversion

Total Voting Rights

Β 

Β 

The Board of Xtract Resources Plc ("Xtract" or the "Company") announces that the Company has received a conversion notice from Auroch Exploration (Pty) Ltd ("Auroch") to convert US$27,736 of the outstanding Convertible Loan Notes.

Β 

As announced on 9 February 2017, the Company reached an agreement regarding the outstanding amounts owed by the Company to Auroch in relation to the acquisition of the Manica Gold Project and, inter alia, agreed to issue unsecured Convertible Loan Notes to Auroch to the total value of US$748,136.

Β 

Following receipt of notice from Auroch to convert a further US$27,736 of the outstanding Convertible Loan Notes, the Company has today issued 134,835,331 new ordinary shares to Auroch at an issue price of 0.016492p (equal to a 15 per cent. discount to the VWAP during the 10 business days prior to the issue of this Conversion Notice).

Β 

The Company has also repaid the outstanding balance of Convertible Loan Notes amounting to US$316,011.

Β 

Β Accordingly, following the conversion and repayment detailed above, there is no further outstanding amount on the Convertible Loan Notes.

Β 

Admission to Aim

Application will be made for admission of the 134,835,331 new ordinary shares to trading on AIM ("Admission"), to be admitted to trading on or around 4 April 2017. The New Shares will rank pari passu in all respects with the Company's existing issued ordinary shares.

Β 

Total Voting Rights

On Admission of the New Shares, the Company will have 32,634,215,952 Ordinary Shares in issue with voting rights. Xtract does not currently hold any shares in treasury. Accordingly, this figure of 32,634,215,952 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Β 

Other

This announcement contains inside information for the purposes of Article 7 of EU Regulation No. 596/2014 on market abuse. Upon the publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

Β 

Further details are available from the Company'sΒ website which details the company's project portfolio as well as a copy of this announcement:Β www.xtractresources.com

Β 

Β 

Enquiries:

Xtract Resources Plc

Colin Bird, Executive Chairman

Β 

+44 (0)20 3416 6471

Β 

Beaumont Cornish

Michael Cornish

Roland Cornish

Felicity Geidt

+44 (0)207628 3369

Email: corpfin@b-cornish.co.uk

Β 

Beaufort Securities

Jon Belliss

Β 

+44 (0)207 382 8300

Β 

ENDS

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCMMGZFDRRGNZM
Date   Source Headline
5th Jul 202310:28 amRNSNotice of AGM
29th Jun 20234:16 pmRNSFinal Results
20th Jun 202312:55 pmRNSAccounts and Annual General Meeting update
6th Apr 20237:00 amRNSFourth quarter 2022 production update
30th Mar 20237:00 amRNSChange of auditor
7th Mar 20234:35 pmRNSPrice Monitoring Extension
7th Mar 20237:00 amRNSUpdate on Open Pit Mining Study for Bushranger
26th Jan 20237:00 amRNSKakuyu Copper Project Zambia update
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
13th Jan 20239:44 amRNSDirector/PDMR Shareholding
9th Jan 20231:25 pmRNSThird quarter 2022 production update
19th Dec 202211:42 amRNSAscot Prospect Maiden Mineral Resource
15th Dec 20223:53 pmRNSKakuyu copper project Zambia
8th Dec 20224:08 pmRNSHolding(s) in Company
5th Dec 202210:32 amRNSTotal Voting Rights
23rd Nov 202211:05 amRNSSecond Price Monitoring Extn
23rd Nov 202211:00 amRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSRacecourse Prospect Updated Mineral Resource
22nd Nov 202212:21 pmRNSApplication update
4th Nov 202210:43 amRNSAward of share options and settlement shares
6th Oct 202211:00 amRNSAscot Prospect final assay results
30th Sep 202210:52 amRNSHalf-year Report
30th Sep 20227:00 amRNSProduction update
24th Aug 202210:20 amRNSResult of AGM
15th Aug 20221:05 pmRNSBushranger results of metallurgical test work
8th Aug 20224:40 pmRNSSecond Price Monitoring Extn
8th Aug 20224:35 pmRNSPrice Monitoring Extension
8th Aug 20222:06 pmRNSSecond Price Monitoring Extn
8th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 20229:13 amRNSBushranger completion of phase two drilling
29th Jul 202211:37 amRNSNotice of AGM
27th Jul 202212:14 pmRNSBushranger assay results and drilling update
21st Jul 20227:00 amRNSFair Bride Update
7th Jul 202212:18 pmRNSBushranger assay results and drilling update
1st Jul 202211:06 amRNSSecond Price Monitoring Extn
1st Jul 202211:00 amRNSPrice Monitoring Extension
30th Jun 20224:33 pmRNSFinal Results
22nd Jun 20229:06 amRNSProduction Update
31st May 202211:14 amRNSAscot Prospect Drill Results Summary
27th May 20223:03 pmRNSBushranger Project Assay Results
17th May 20229:14 amRNSBushranger Project Assay Results
10th May 20227:00 amRNSBushranger Project Assay Results
9th May 20225:27 pmRNSTotal Voting Rights
22nd Apr 20227:00 amRNSExercise of warrants
6th Apr 20227:00 amRNSBushranger Project Drilling Update
31st Mar 202212:19 pmRNSBushranger Project Assay Results
21st Mar 20226:12 pmRNSChange of auditor
21st Mar 20227:00 amRNSBushranger Project Assay Results
7th Mar 20227:00 amRNSBushranger Project Assay Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.